pentoxifylline has been researched along with Colitis, Granulomatous in 8 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sixteen Crohn's disease patients received oxpentifylline 400 mg four times a day in a four week open label study." | 2.68 | Treatment with tumour necrosis factor inhibitor oxpentifylline does not improve corticosteroid dependent chronic active Crohn's disease. ( Bauditz, J; Haemling, J; Lochs, H; Ortner, M; Raedler, A; Schreiber, S, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (62.50) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Berera, S | 1 |
| Ioannou, SC | 1 |
| Morillo, D | 1 |
| Mantero, AMA | 1 |
| Pignac-Kobinger, J | 1 |
| Colina, N | 1 |
| Santander, AM | 1 |
| Fernandez, I | 1 |
| Quintero, MA | 1 |
| Rodriguez, J | 1 |
| Kerman, DH | 1 |
| Damas, OM | 1 |
| Czul, F | 1 |
| Sussman, DA | 1 |
| Abreu, MT | 1 |
| Deshpande, AR | 1 |
| Korzenik, JR | 1 |
| Bauditz, J | 2 |
| Rückert, Y | 1 |
| Raedler, A | 2 |
| Nikolaus, S | 1 |
| Lochs, H | 2 |
| Schreiber, S | 2 |
| Haemling, J | 1 |
| Ortner, M | 1 |
| Reimund, JM | 1 |
| Dumont, S | 1 |
| Muller, CD | 1 |
| Kenney, JS | 1 |
| Kedinger, M | 1 |
| Baumann, R | 1 |
| Poindron, P | 1 |
| Duclos, B | 1 |
| MacDonald, TT | 1 |
| Lémann, M | 1 |
| Raza, A | 1 |
3 reviews available for pentoxifylline and Colitis, Granulomatous
| Article | Year |
|---|---|
Crohn's disease: future anti-tumor necrosis factor therapies beyond infliximab.
Topics: Antibodies, Monoclonal; Crohn Disease; Etanercept; Humans; Immunoglobulin G; Immunosuppressive Agent | 2004 |
[Treatment of Crohn's disease with anti-TNF alpha].
Topics: Antibodies, Monoclonal; Crohn Disease; Free Radical Scavengers; Humans; Immunotherapy; Pentoxifyllin | 1998 |
Anti-TNF therapies in rheumatoid arthritis, Crohn's disease, sepsis, and myelodysplastic syndromes.
Topics: Arthritis, Rheumatoid; Crohn Disease; Etanercept; Humans; Immunoglobulin G; Myelodysplastic Syndrome | 2000 |
2 trials available for pentoxifylline and Colitis, Granulomatous
| Article | Year |
|---|---|
Combining Pentoxifylline With Vedolizumab for Crohn's Disease: Results of a Randomised, Placebo-controlled Pilot Study.
Topics: Adult; C-Reactive Protein; Crohn Disease; Gastrointestinal Agents; Humans; Pentoxifylline; Pilot Pro | 2022 |
Treatment with tumour necrosis factor inhibitor oxpentifylline does not improve corticosteroid dependent chronic active Crohn's disease.
Topics: Adult; Anti-Inflammatory Agents; Cells, Cultured; Chronic Disease; Crohn Disease; Drug Therapy, Comb | 1997 |
3 other studies available for pentoxifylline and Colitis, Granulomatous
| Article | Year |
|---|---|
Tumour necrosis factor inhibition by oxpentifylline and intestinal inflammation in Crohn's disease.
Topics: Adult; Colitis; Crohn Disease; Female; Humans; Male; Pentoxifylline; Tumor Necrosis Factor-alpha | 1995 |
In vitro effects of oxpentifylline on inflammatory cytokine release in patients with inflammatory bowel disease.
Topics: Adult; Colitis, Ulcerative; Colon; Crohn Disease; Culture Techniques; Cytokines; Female; Humans; Inf | 1997 |
Oxpentifylline, tumour necrosis factor-alpha and Crohn's disease.
Topics: Crohn Disease; Humans; Pentoxifylline; Phosphodiesterase Inhibitors; Treatment Failure; Tumor Necros | 1997 |